Structure

Physi-Chem Properties

Molecular Weight:  574.29
Volume:  600.381
LogP:  5.458
LogD:  3.879
LogS:  -4.664
# Rotatable Bonds:  3
TPSA:  125.04
# H-Bond Aceptor:  7
# H-Bond Donor:  3
# Rings:  6
# Heavy Atoms:  7

MedChem Properties

QED Drug-Likeness Score:  0.292
Synthetic Accessibility Score:  5.193
Fsp3:  0.571
Lipinski Rule-of-5:  Rejected
Pfizer Rule:  Accepted
GSK Rule:  Rejected
BMS Rule:  0
Golden Triangle Rule:  Rejected
Chelating Alert:  0
PAINS Alert:  1

ADMET Properties (ADMETlab2.0)

ADMET: Absorption

Caco-2 Permeability:  -5.224
MDCK Permeability:  1.4483051018032711e-05
Pgp-inhibitor:  0.838
Pgp-substrate:  0.995
Human Intestinal Absorption (HIA):  0.008
20% Bioavailability (F20%):  0.843
30% Bioavailability (F30%):  0.65

ADMET: Distribution

Blood-Brain-Barrier Penetration (BBB):  0.055
Plasma Protein Binding (PPB):  89.39832305908203%
Volume Distribution (VD):  0.75
Pgp-substrate:  5.919275283813477%

ADMET: Metabolism

CYP1A2-inhibitor:  0.093
CYP1A2-substrate:  0.453
CYP2C19-inhibitor:  0.715
CYP2C19-substrate:  0.253
CYP2C9-inhibitor:  0.797
CYP2C9-substrate:  0.716
CYP2D6-inhibitor:  0.655
CYP2D6-substrate:  0.307
CYP3A4-inhibitor:  0.85
CYP3A4-substrate:  0.351

ADMET: Excretion

Clearance (CL):  10.732
Half-life (T1/2):  0.046

ADMET: Toxicity

hERG Blockers:  0.525
Human Hepatotoxicity (H-HT):  0.211
Drug-inuced Liver Injury (DILI):  0.111
AMES Toxicity:  0.207
Rat Oral Acute Toxicity:  0.674
Maximum Recommended Daily Dose:  0.969
Skin Sensitization:  0.58
Carcinogencity:  0.713
Eye Corrosion:  0.003
Eye Irritation:  0.427
Respiratory Toxicity:  0.976

Download Data

Data Type Select
General Info & Identifiers & Properties  
Structure MOL file  
Source Organisms  
Biological Activities  
Similar NPs/Drugs  

  Natural Product: NPC469394

Natural Product ID:  NPC469394
Common Name*:   Dichrostachine O
IUPAC Name:   2-[(4R,4aS,8aR)-4-[[(1R,3S,4aS,8aS)-3-hydroxy-5,5,8a-trimethyl-2-methylidene-3,4,4a,6,7,8-hexahydro-1H-naphthalen-1-yl]methyl]-8-hydroxy-7-methoxy-3-methyl-5-oxo-1,4,8,8a-tetrahydronaphthalen-4a-yl]-5,7-dihydroxychromen-4-one
Synonyms:   Dichrostachine O
Standard InCHIKey:  LVNKBVBEDBVHKZ-NINURHNOSA-N
Standard InCHI:  InChI=1S/C36H44O8/c1-18-8-9-21-33(42)28(43-6)17-30(41)36(21,31-16-26(40)32-25(39)12-20(37)13-27(32)44-31)22(18)14-23-19(2)24(38)15-29-34(3,4)10-7-11-35(23,29)5/h8,12-13,16-17,21-24,29,33,37-39,42H,2,7,9-11,14-15H2,1,3-6H3/t21-,22+,23-,24-,29-,33?,35+,36-/m0/s1
SMILES:  COC1=CC(=O)[C@@]2([C@H](C1O)CC=C([C@H]2C[C@H]1C(=C)[C@@H](O)C[C@@H]2[C@]1(C)CCCC2(C)C)C)c1cc(=O)c2c(o1)cc(cc2O)O
Synthetic Gene Cluster:   n.a.
ChEMBL Identifier:   CHEMBL1077627
PubChem CID:   44557417
Chemical Classification**:  
  • CHEMONTID:0000000 [Organic compounds]
    • [CHEMONTID:0000012] Lipids and lipid-like molecules
      • [CHEMONTID:0000259] Prenol lipids
        • [CHEMONTID:0001551] Diterpenoids

*Note: the InCHIKey will be temporarily assigned as the "Common Name" if no IUPAC name or alternative short name is available.
**Note: the Chemical Classification was calculated by NPClassifier Version 1.5. Reference: PMID:34662515.

  Species Source

Organism ID Organism Name Taxonomy Level Family SuperKingdom Isolation Part Collection Location Collection Time Reference
NPO15669 Dichrostachys cinerea Species Fabaceae Eukaryota n.a. n.a. n.a. PMID[19761234]
NPO15669 Dichrostachys cinerea Species Fabaceae Eukaryota n.a. n.a. n.a. Database[UNPD]

☑ Note for Reference:
In addition to directly collecting NP source organism data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated them from below databases:
UNPD: Universal Natural Products Database [PMID: 23638153].
StreptomeDB: a database of streptomycetes natural products [PMID: 33051671].
TM-MC: a database of medicinal materials and chemical compounds in Northeast Asian traditional medicine [PMID: 26156871].
TCM@Taiwan: a Traditional Chinese Medicine database [PMID: 21253603].
TCMID: a Traditional Chinese Medicine database [PMID: 29106634].
TCMSP: The traditional Chinese medicine systems pharmacology database and analysis platform [PMID: 24735618].
HerDing: a herb recommendation system to treat diseases using genes and chemicals [PMID: 26980517].
MetaboLights: a metabolomics database [PMID: 27010336].
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].

  NP Quantity Composition/Concentration

Organism ID NP ID Organism Material Preparation Organism Part NP Quantity (Standard) NP Quantity (Minimum) NP Quantity (Maximum) Quantity Unit Reference

☑ Note for Reference:
In addition to directly collecting NP quantitative data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated NP quantitative records for specific NP domains (e.g., NPS from foods or herbs) from domain-specific databases. These databases include:
DUKE: Dr. Duke's Phytochemical and Ethnobotanical Databases.
PHENOL EXPLORER: is the first comprehensive database on polyphenol content in foods [PMID: 24103452], its homepage can be accessed at here.
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].

  Biological Activity

Target ID Target Type Target Name Target Organism Activity Type Activity Relation Value Unit Reference
NPT2 Others Unspecified IC50 = 25000.0 nM PMID[571168]
NPT20529 NON-MOLECULAR NON-PROTEIN TARGET n.a. Activity > 10.0 uM PMID[571168]

☑ Note for Activity Records:
☉ The quantitative biological activities were primarily integrated from ChEMBL (Version-30) database and were also directly collected from PubMed literature. PubMed PMID was provided as the reference link for each activity record.

  Chemically structural similarity: I. Similar Active Natural Products in NPASS

Top-200 similar NPs were calculated against the active-NP-set (includes 4,3285 NPs with experimentally-derived bioactivity available in NPASS)

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules. Tc lies between [0, 1] where '1' indicates the highest similarity. What is Tanimoto coefficient

●  The left chart: Distribution of similarity level between NPC469394 and all remaining natural products in the NPASS database.
●  The right table: Most similar natural products (Tc>=0.56 or Top200).

Similarity Score Similarity Level Natural Product ID
0.9568 High Similarity NPC469393
0.9383 High Similarity NPC286074
0.9383 High Similarity NPC54903
0.9379 High Similarity NPC85047
0.9379 High Similarity NPC17274
0.9379 High Similarity NPC120857
0.9375 High Similarity NPC469395
0.9264 High Similarity NPC20734
0.9207 High Similarity NPC193698
0.913 High Similarity NPC61382
0.913 High Similarity NPC103816
0.9119 High Similarity NPC164427
0.9096 High Similarity NPC471969
0.9042 High Similarity NPC294149
0.903 High Similarity NPC188079
0.9018 High Similarity NPC476295
0.897 High Similarity NPC472622
0.8951 High Similarity NPC472055
0.8938 High Similarity NPC68727
0.8931 High Similarity NPC470337
0.8931 High Similarity NPC113608
0.8931 High Similarity NPC268992
0.8931 High Similarity NPC51824
0.8931 High Similarity NPC470338
0.8922 High Similarity NPC472620
0.8916 High Similarity NPC102810
0.8909 High Similarity NPC472621
0.8889 High Similarity NPC472617
0.8889 High Similarity NPC470339
0.8862 High Similarity NPC315306
0.8862 High Similarity NPC313717
0.8862 High Similarity NPC251144
0.8862 High Similarity NPC241387
0.8861 High Similarity NPC307052
0.8861 High Similarity NPC139966
0.8855 High Similarity NPC478060
0.8855 High Similarity NPC470374
0.8855 High Similarity NPC471975
0.8855 High Similarity NPC470377
0.8855 High Similarity NPC478059
0.8834 High Similarity NPC472618
0.8834 High Similarity NPC297212
0.882 High Similarity NPC175192
0.8812 High Similarity NPC56232
0.8812 High Similarity NPC244583
0.8812 High Similarity NPC470340
0.8812 High Similarity NPC180944
0.8812 High Similarity NPC161881
0.8812 High Similarity NPC150123
0.8812 High Similarity NPC10807
0.881 High Similarity NPC118128
0.8802 High Similarity NPC472619
0.8797 High Similarity NPC10097
0.8795 High Similarity NPC178173
0.8788 High Similarity NPC12461
0.8773 High Similarity NPC197856
0.8773 High Similarity NPC46736
0.8765 High Similarity NPC192587
0.8765 High Similarity NPC98943
0.8765 High Similarity NPC478050
0.8758 High Similarity NPC112701
0.8758 High Similarity NPC326592
0.8758 High Similarity NPC109594
0.8758 High Similarity NPC155686
0.8758 High Similarity NPC469405
0.8757 High Similarity NPC475080
0.875 High Similarity NPC328740
0.875 High Similarity NPC207346
0.875 High Similarity NPC209846
0.875 High Similarity NPC289774
0.875 High Similarity NPC473131
0.875 High Similarity NPC470675
0.875 High Similarity NPC477897
0.875 High Similarity NPC46564
0.8743 High Similarity NPC105414
0.8743 High Similarity NPC324522
0.8743 High Similarity NPC234497
0.8743 High Similarity NPC470341
0.8743 High Similarity NPC472058
0.8735 High Similarity NPC469664
0.8727 High Similarity NPC206605
0.8727 High Similarity NPC472059
0.872 High Similarity NPC195136
0.872 High Similarity NPC101731
0.872 High Similarity NPC470810
0.872 High Similarity NPC476280
0.8712 High Similarity NPC257166
0.8712 High Similarity NPC183851
0.8712 High Similarity NPC63454
0.8704 High Similarity NPC470681
0.8704 High Similarity NPC304745
0.8704 High Similarity NPC111341
0.8698 High Similarity NPC476159
0.869 High Similarity NPC297195
0.869 High Similarity NPC475212
0.869 High Similarity NPC207574
0.869 High Similarity NPC291795
0.8688 High Similarity NPC225854
0.8683 High Similarity NPC207575
0.8683 High Similarity NPC13481
0.8683 High Similarity NPC320741
0.8683 High Similarity NPC476255
0.8683 High Similarity NPC171985
0.8683 High Similarity NPC251336
0.8675 High Similarity NPC63438
0.8675 High Similarity NPC472053
0.8675 High Similarity NPC474240
0.8667 High Similarity NPC305987
0.8667 High Similarity NPC113163
0.8667 High Similarity NPC97812
0.8667 High Similarity NPC278427
0.8667 High Similarity NPC288131
0.8667 High Similarity NPC165970
0.8667 High Similarity NPC142252
0.8667 High Similarity NPC66618
0.8667 High Similarity NPC87431
0.8667 High Similarity NPC158188
0.8667 High Similarity NPC26326
0.8667 High Similarity NPC84324
0.8663 High Similarity NPC244903
0.8659 High Similarity NPC172202
0.8659 High Similarity NPC51247
0.8659 High Similarity NPC476410
0.8659 High Similarity NPC15815
0.8659 High Similarity NPC105584
0.8659 High Similarity NPC117418
0.8659 High Similarity NPC284127
0.8659 High Similarity NPC90497
0.8659 High Similarity NPC53545
0.8655 High Similarity NPC469345
0.8655 High Similarity NPC46958
0.865 High Similarity NPC215917
0.865 High Similarity NPC32867
0.865 High Similarity NPC56049
0.865 High Similarity NPC20530
0.865 High Similarity NPC54830
0.865 High Similarity NPC10754
0.865 High Similarity NPC78492
0.865 High Similarity NPC208152
0.8647 High Similarity NPC213052
0.8642 High Similarity NPC223701
0.8642 High Similarity NPC7989
0.8642 High Similarity NPC268193
0.8642 High Similarity NPC472583
0.8634 High Similarity NPC474021
0.8634 High Similarity NPC178484
0.8634 High Similarity NPC474023
0.8634 High Similarity NPC46882
0.8634 High Similarity NPC471677
0.8634 High Similarity NPC132990
0.8631 High Similarity NPC218226
0.8631 High Similarity NPC243877
0.8631 High Similarity NPC223413
0.8631 High Similarity NPC470456
0.8631 High Similarity NPC193222
0.8631 High Similarity NPC474024
0.8631 High Similarity NPC476306
0.8631 High Similarity NPC260266
0.8625 High Similarity NPC471114
0.8623 High Similarity NPC472057
0.8623 High Similarity NPC472049
0.8623 High Similarity NPC475888
0.8623 High Similarity NPC472051
0.8623 High Similarity NPC314653
0.8623 High Similarity NPC316262
0.8623 High Similarity NPC294722
0.8616 High Similarity NPC91902
0.8616 High Similarity NPC470670
0.8616 High Similarity NPC473133
0.8616 High Similarity NPC85773
0.8616 High Similarity NPC47388
0.8614 High Similarity NPC211107
0.8614 High Similarity NPC201800
0.8614 High Similarity NPC474150
0.8614 High Similarity NPC473012
0.8614 High Similarity NPC474162
0.8613 High Similarity NPC208069
0.8608 High Similarity NPC224714
0.8606 High Similarity NPC155302
0.8606 High Similarity NPC475784
0.8606 High Similarity NPC299436
0.8606 High Similarity NPC472631
0.8606 High Similarity NPC161947
0.8606 High Similarity NPC321399
0.8606 High Similarity NPC472630
0.8606 High Similarity NPC476283
0.8605 High Similarity NPC476199
0.8605 High Similarity NPC476210
0.8598 High Similarity NPC475184
0.8598 High Similarity NPC271741
0.8598 High Similarity NPC272196
0.8598 High Similarity NPC287789
0.8598 High Similarity NPC1796
0.8596 High Similarity NPC86809
0.8596 High Similarity NPC477992
0.8596 High Similarity NPC477991
0.8596 High Similarity NPC232412
0.8596 High Similarity NPC475398
0.8596 High Similarity NPC98667
0.8589 High Similarity NPC217706

  Chemically structural similarity: II. Similar Clinical/Approved Drugs

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules.

●  The left chart: Distribution of similarity level between NPC469394 and all drugs/candidates.
●  The right table: Most similar clinical/approved drugs (Tc>=0.56 or Top200).

Similarity Score Similarity Level Drug ID Developmental Stage
0.8589 High Similarity NPD8443 Clinical (unspecified phase)
0.8571 High Similarity NPD4380 Phase 2
0.8512 High Similarity NPD6166 Phase 2
0.8512 High Similarity NPD6167 Clinical (unspecified phase)
0.8512 High Similarity NPD6168 Clinical (unspecified phase)
0.8471 Intermediate Similarity NPD7804 Clinical (unspecified phase)
0.8443 Intermediate Similarity NPD6959 Discontinued
0.8415 Intermediate Similarity NPD2393 Clinical (unspecified phase)
0.8373 Intermediate Similarity NPD4381 Clinical (unspecified phase)
0.8363 Intermediate Similarity NPD7054 Approved
0.8354 Intermediate Similarity NPD1934 Approved
0.8314 Intermediate Similarity NPD7074 Phase 3
0.8314 Intermediate Similarity NPD7472 Approved
0.8303 Intermediate Similarity NPD2801 Approved
0.8276 Intermediate Similarity NPD7808 Phase 3
0.8263 Intermediate Similarity NPD7075 Discontinued
0.8261 Intermediate Similarity NPD4378 Clinical (unspecified phase)
0.8246 Intermediate Similarity NPD7473 Discontinued
0.8218 Intermediate Similarity NPD7251 Discontinued
0.8204 Intermediate Similarity NPD4868 Clinical (unspecified phase)
0.8198 Intermediate Similarity NPD3818 Discontinued
0.8193 Intermediate Similarity NPD7819 Suspended
0.8161 Intermediate Similarity NPD6797 Phase 2
0.8148 Intermediate Similarity NPD7410 Clinical (unspecified phase)
0.8133 Intermediate Similarity NPD6801 Discontinued
0.8086 Intermediate Similarity NPD1511 Approved
0.8084 Intermediate Similarity NPD7096 Clinical (unspecified phase)
0.807 Intermediate Similarity NPD6232 Discontinued
0.8063 Intermediate Similarity NPD2800 Approved
0.8059 Intermediate Similarity NPD5494 Approved
0.8057 Intermediate Similarity NPD7993 Clinical (unspecified phase)
0.805 Intermediate Similarity NPD1552 Clinical (unspecified phase)
0.805 Intermediate Similarity NPD1550 Clinical (unspecified phase)
0.8036 Intermediate Similarity NPD3817 Phase 2
0.8012 Intermediate Similarity NPD6599 Discontinued
0.8 Intermediate Similarity NPD1549 Phase 2
0.7989 Intermediate Similarity NPD8434 Phase 2
0.7988 Intermediate Similarity NPD3882 Suspended
0.7988 Intermediate Similarity NPD1512 Approved
0.7987 Intermediate Similarity NPD2796 Approved
0.7977 Intermediate Similarity NPD7852 Clinical (unspecified phase)
0.7966 Intermediate Similarity NPD4338 Clinical (unspecified phase)
0.7964 Intermediate Similarity NPD7411 Suspended
0.7943 Intermediate Similarity NPD5844 Phase 1
0.7929 Intermediate Similarity NPD5402 Approved
0.7925 Intermediate Similarity NPD1510 Phase 2
0.7921 Intermediate Similarity NPD8312 Approved
0.7921 Intermediate Similarity NPD8313 Approved
0.7912 Intermediate Similarity NPD7879 Clinical (unspecified phase)
0.7911 Intermediate Similarity NPD6651 Approved
0.7901 Intermediate Similarity NPD8397 Clinical (unspecified phase)
0.7889 Intermediate Similarity NPD8150 Discontinued
0.7888 Intermediate Similarity NPD970 Clinical (unspecified phase)
0.7882 Intermediate Similarity NPD7768 Phase 2
0.7875 Intermediate Similarity NPD6100 Approved
0.7875 Intermediate Similarity NPD6099 Approved
0.7831 Intermediate Similarity NPD5403 Approved
0.7818 Intermediate Similarity NPD2533 Approved
0.7818 Intermediate Similarity NPD2532 Approved
0.7818 Intermediate Similarity NPD2534 Approved
0.7809 Intermediate Similarity NPD6559 Discontinued
0.7791 Intermediate Similarity NPD4628 Phase 3
0.7791 Intermediate Similarity NPD3750 Approved
0.7758 Intermediate Similarity NPD6799 Approved
0.7711 Intermediate Similarity NPD5401 Approved
0.7688 Intermediate Similarity NPD1607 Approved
0.7684 Intermediate Similarity NPD3751 Discontinued
0.7684 Intermediate Similarity NPD7228 Approved
0.7683 Intermediate Similarity NPD6398 Clinical (unspecified phase)
0.7673 Intermediate Similarity NPD1240 Approved
0.7668 Intermediate Similarity NPD8151 Discontinued
0.7661 Intermediate Similarity NPD1465 Phase 2
0.7651 Intermediate Similarity NPD7390 Discontinued
0.763 Intermediate Similarity NPD3749 Approved
0.7602 Intermediate Similarity NPD37 Approved
0.7586 Intermediate Similarity NPD6234 Discontinued
0.7572 Intermediate Similarity NPD4966 Approved
0.7572 Intermediate Similarity NPD4965 Approved
0.7572 Intermediate Similarity NPD4967 Phase 2
0.7558 Intermediate Similarity NPD5760 Phase 2
0.7558 Intermediate Similarity NPD5761 Phase 2
0.7557 Intermediate Similarity NPD3787 Discontinued
0.7553 Intermediate Similarity NPD8090 Clinical (unspecified phase)
0.7541 Intermediate Similarity NPD8055 Clinical (unspecified phase)
0.7529 Intermediate Similarity NPD3226 Approved
0.7529 Intermediate Similarity NPD7458 Discontinued
0.75 Intermediate Similarity NPD7004 Clinical (unspecified phase)
0.75 Intermediate Similarity NPD8127 Discontinued
0.7485 Intermediate Similarity NPD3748 Approved
0.7485 Intermediate Similarity NPD1509 Clinical (unspecified phase)
0.7473 Intermediate Similarity NPD4419 Clinical (unspecified phase)
0.7438 Intermediate Similarity NPD6410 Clinical (unspecified phase)
0.7435 Intermediate Similarity NPD6779 Approved
0.7435 Intermediate Similarity NPD6780 Approved
0.7435 Intermediate Similarity NPD6781 Approved
0.7435 Intermediate Similarity NPD6782 Approved
0.7435 Intermediate Similarity NPD6776 Approved
0.7435 Intermediate Similarity NPD6777 Approved
0.7435 Intermediate Similarity NPD6778 Approved
0.7411 Intermediate Similarity NPD7783 Phase 2
0.7411 Intermediate Similarity NPD7782 Clinical (unspecified phase)
0.741 Intermediate Similarity NPD7421 Clinical (unspecified phase)
0.7409 Intermediate Similarity NPD7696 Phase 3
0.7409 Intermediate Similarity NPD7435 Discontinued
0.7409 Intermediate Similarity NPD7697 Approved
0.7409 Intermediate Similarity NPD7698 Approved
0.7401 Intermediate Similarity NPD7199 Phase 2
0.7371 Intermediate Similarity NPD7871 Phase 2
0.7371 Intermediate Similarity NPD7870 Phase 2
0.7365 Intermediate Similarity NPD8166 Discontinued
0.7365 Intermediate Similarity NPD1878 Clinical (unspecified phase)
0.7356 Intermediate Similarity NPD8455 Phase 2
0.7354 Intermediate Similarity NPD4360 Phase 2
0.7354 Intermediate Similarity NPD4363 Phase 3
0.7347 Intermediate Similarity NPD7701 Phase 2
0.7333 Intermediate Similarity NPD1551 Phase 2
0.7329 Intermediate Similarity NPD6859 Clinical (unspecified phase)
0.7329 Intermediate Similarity NPD4907 Clinical (unspecified phase)
0.7323 Intermediate Similarity NPD7801 Approved
0.7322 Intermediate Similarity NPD7240 Approved
0.7318 Intermediate Similarity NPD3926 Phase 2
0.7312 Intermediate Similarity NPD4908 Phase 1
0.731 Intermediate Similarity NPD920 Approved
0.7303 Intermediate Similarity NPD1247 Approved
0.7294 Intermediate Similarity NPD7422 Clinical (unspecified phase)
0.7288 Intermediate Similarity NPD5537 Clinical (unspecified phase)
0.7273 Intermediate Similarity NPD2799 Discontinued
0.7273 Intermediate Similarity NPD7874 Approved
0.7273 Intermediate Similarity NPD7875 Clinical (unspecified phase)
0.7268 Intermediate Similarity NPD5953 Discontinued
0.7268 Intermediate Similarity NPD6823 Phase 2
0.7263 Intermediate Similarity NPD5710 Approved
0.7263 Intermediate Similarity NPD5711 Approved
0.7254 Intermediate Similarity NPD7501 Clinical (unspecified phase)
0.7253 Intermediate Similarity NPD7286 Phase 2
0.7251 Intermediate Similarity NPD6273 Approved
0.724 Intermediate Similarity NPD7699 Phase 2
0.724 Intermediate Similarity NPD7700 Phase 2
0.7239 Intermediate Similarity NPD943 Approved
0.7239 Intermediate Similarity NPD1613 Approved
0.7239 Intermediate Similarity NPD1612 Clinical (unspecified phase)
0.7229 Intermediate Similarity NPD2935 Discontinued
0.7228 Intermediate Similarity NPD7685 Pre-registration
0.7225 Intermediate Similarity NPD5808 Clinical (unspecified phase)
0.7222 Intermediate Similarity NPD7184 Clinical (unspecified phase)
0.7208 Intermediate Similarity NPD7584 Approved
0.7202 Intermediate Similarity NPD1243 Approved
0.7195 Intermediate Similarity NPD230 Phase 1
0.7194 Intermediate Similarity NPD8320 Phase 1
0.7194 Intermediate Similarity NPD8319 Approved
0.7193 Intermediate Similarity NPD642 Clinical (unspecified phase)
0.7191 Intermediate Similarity NPD919 Approved
0.7188 Intermediate Similarity NPD6917 Clinical (unspecified phase)
0.7186 Intermediate Similarity NPD2346 Discontinued
0.7186 Intermediate Similarity NPD2344 Approved
0.7182 Intermediate Similarity NPD2403 Approved
0.7173 Intermediate Similarity NPD6534 Approved
0.7173 Intermediate Similarity NPD6535 Approved
0.717 Intermediate Similarity NPD8651 Approved
0.7167 Intermediate Similarity NPD7229 Phase 3
0.716 Intermediate Similarity NPD7003 Approved
0.7117 Intermediate Similarity NPD2313 Discontinued
0.711 Intermediate Similarity NPD6980 Clinical (unspecified phase)
0.7091 Intermediate Similarity NPD5124 Phase 1
0.7091 Intermediate Similarity NPD5123 Clinical (unspecified phase)
0.7087 Intermediate Similarity NPD7907 Approved
0.7076 Intermediate Similarity NPD643 Clinical (unspecified phase)
0.7066 Intermediate Similarity NPD7033 Discontinued
0.7066 Intermediate Similarity NPD651 Clinical (unspecified phase)
0.7055 Intermediate Similarity NPD3027 Phase 3
0.7047 Intermediate Similarity NPD4362 Clinical (unspecified phase)
0.7047 Intermediate Similarity NPD4361 Phase 2
0.7045 Intermediate Similarity NPD7615 Clinical (unspecified phase)
0.7037 Intermediate Similarity NPD1530 Clinical (unspecified phase)
0.7026 Intermediate Similarity NPD8285 Discontinued
0.7018 Intermediate Similarity NPD6190 Approved
0.7018 Intermediate Similarity NPD2309 Approved
0.7012 Intermediate Similarity NPD3268 Approved
0.7006 Intermediate Similarity NPD7097 Phase 1
0.7006 Intermediate Similarity NPD6844 Discontinued
0.7 Intermediate Similarity NPD4749 Approved
0.7 Intermediate Similarity NPD6674 Discontinued
0.6995 Remote Similarity NPD7784 Clinical (unspecified phase)
0.6994 Remote Similarity NPD1529 Clinical (unspecified phase)
0.6994 Remote Similarity NPD6832 Phase 2
0.699 Remote Similarity NPD4111 Phase 1
0.699 Remote Similarity NPD4665 Approved
0.6988 Remote Similarity NPD6355 Discontinued
0.6988 Remote Similarity NPD447 Suspended
0.6981 Remote Similarity NPD1610 Phase 2
0.6977 Remote Similarity NPD3300 Phase 2
0.6976 Remote Similarity NPD8404 Phase 2
0.6975 Remote Similarity NPD2798 Approved
0.6971 Remote Similarity NPD1653 Approved
0.6963 Remote Similarity NPD8361 Approved
0.6963 Remote Similarity NPD8360 Approved
0.6952 Remote Similarity NPD8368 Discontinued
0.6943 Remote Similarity NPD6214 Clinical (unspecified phase)
0.6943 Remote Similarity NPD6212 Phase 3
0.6943 Remote Similarity NPD6213 Phase 3

  Bioactivity similarity: Similar Natural Products in NPASS

Bioactivity similarity was calculated based on bioactivity descriptors of compounds. The bioactivity descriptors were calculated by a recently developed AI algorithm Chemical Checker (CC) [Nature Biotechnology, 38:1087–1096, 2020; Nature Communications, 12:3932, 2021], which evaluated bioactivity similarities at five levels:
A: chemistry similarity;
B: biological targets similarity;
C: networks similarity;
D: cell-based bioactivity similarity;
E: similarity based on clinical data.

Those 5 categories of CC bioactivity descriptors were calculated and then subjected to manifold projection using UMAP algorithm, to project all NPs on a 2-Dimensional space. The current NP was highlighted with a small circle in the 2-D map. Below figures: left-to-right, A-to-E.

A: chemistry similarity
B: biological targets similarity
C: networks similarity
D: cell-based bioactivity similarity
E: similarity based on clinical data